Literature DB >> 1782749

HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis.

P J Charles1, M C Sweatman, J R Markwick, R N Maini.   

Abstract

We have compared the frequency of HLA antigens in groups of patients with rheumatoid arthritis (RA) who had pulmonary manifestations, other extra-articular features or articular disease alone. There was a significantly increased frequency of the antigen HLA-B40 in patients with lung involvement compared to other forms of extra-articular RA (relative risk 40.54), and when compared to the total RA group (relative risk 4.94). In contrast there was little variation in the frequency of HLA-DR4, which was significantly increased in all patient groups. These data suggest that HLA-B40 is a marker of increased susceptibility to lung disease in patients with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1782749

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  10 in total

Review 1.  Lung disease in rheumatoid arthritis.

Authors:  Zulma X Yunt; Joshua J Solomon
Journal:  Rheum Dis Clin North Am       Date:  2015-02-03       Impact factor: 2.670

Review 2.  Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.

Authors:  Kundan Iqbal; Clive Kelly
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

3.  Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study.

Authors:  Dimitrios A Pappas; Jon T Giles; Geoffrey Connors; Noah Lechtzin; Joan M Bathon; Sonye K Danoff
Journal:  Arthritis Res Ther       Date:  2010-05-27       Impact factor: 5.156

Review 4.  Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.

Authors:  Eunice J Kim; Harold R Collard; Talmadge E King
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

Review 5.  Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.

Authors:  Yujie Dai; Weina Wang; Yikai Yu; Shaoxian Hu
Journal:  Clin Rheumatol       Date:  2020-08-13       Impact factor: 2.980

6.  Interstitial lung disease in rheumatoid arthritis in the era of biologics.

Authors:  A Picchianti Diamanti; V Germano; E Bizzi; B Laganà; A Migliore
Journal:  Pulm Med       Date:  2011-12-20

7.  Interstitial Lung Disease of the UIP Variant as the Only Presenting Symptom of Rheumatoid Arthritis.

Authors:  Abhinav Agrawal; Braghadheeswar Thyagarajan; Sidney Ceniza; Syed Hasan Yusuf
Journal:  Case Rep Pulmonol       Date:  2015-06-07

Review 8.  Rheumatoid arthritis-associated interstitial lung disease.

Authors:  Joshua J Solomon; Kevin K Brown
Journal:  Open Access Rheumatol       Date:  2012-03-05

Review 9.  Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians.

Authors:  Elisabeth Bendstrup; Janne Møller; Sissel Kronborg-White; Thomas Skovhus Prior; Charlotte Hyldgaard
Journal:  J Clin Med       Date:  2019-11-21       Impact factor: 4.241

10.  Demographic and disease-related predictors of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population.

Authors:  Suzanne M M Verstappen; Mark Lunt; Robert N Luben; Jackie Chipping; Tarnya Marshall; Kay-Tee Khaw; Nick Wareham; William G Dixon; Ian N Bruce; Deborah P M Symmons
Journal:  Ann Rheum Dis       Date:  2012-10-13       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.